| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Approved drugs for multiple sclerosis: the challenge of choice
|
Sormani, Maria Pia
|
|
2017
|
16 |
4 |
p. 252-253
2 p.
|
article
|
| 2 |
Cognitive decline before diagnosis of Parkinson's disease
|
Darweesh, Sirwan KL
|
|
2017
|
16 |
4 |
p. 262-
1 p.
|
article
|
| 3 |
Cognitive decline before diagnosis of Parkinson's disease – Authors' reply
|
Schrag, Anette
|
|
2017
|
16 |
4 |
p. 262-
1 p.
|
article
|
| 4 |
Corrections
|
|
|
2017
|
16 |
4 |
p. 261-
1 p.
|
article
|
| 5 |
Corrections
|
|
|
2017
|
16 |
4 |
p. 261-
1 p.
|
article
|
| 6 |
Corrections
|
|
|
2017
|
16 |
4 |
p. 261-
1 p.
|
article
|
| 7 |
Diagnosis and treatment of carpal tunnel syndrome
|
Thomson, J Grant
|
|
2017
|
16 |
4 |
p. 263-
1 p.
|
article
|
| 8 |
Diagnosis and treatment of carpal tunnel syndrome – Authors' response
|
Padua, Luca
|
|
2017
|
16 |
4 |
p. 263-264
2 p.
|
article
|
| 9 |
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial
|
Amarenco, Pierre
|
|
2017
|
16 |
4 |
p. 301-310
10 p.
|
article
|
| 10 |
Epileptic activity in Alzheimer's disease: causes and clinical relevance
|
Vossel, Keith A
|
|
2017
|
16 |
4 |
p. 311-322
12 p.
|
article
|
| 11 |
Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial
|
Wachter, Rolf
|
|
2017
|
16 |
4 |
p. 282-290
9 p.
|
article
|
| 12 |
Investing in autism: better evidence for better care
|
The Lancet Neurology,
|
|
2017
|
16 |
4 |
p. 251-
1 p.
|
article
|
| 13 |
Keith Vossel
|
|
|
2017
|
16 |
4 |
p. 268-
1 p.
|
article
|
| 14 |
Memory, distraction, and nostalgia
|
Ranscombe, Peter
|
|
2017
|
16 |
4 |
p. 269-
1 p.
|
article
|
| 15 |
Neuropathies and diabetes in Jules Verne
|
Perciaccante, Antonio
|
|
2017
|
16 |
4 |
p. 268-
1 p.
|
article
|
| 16 |
Ocrelizumab in multiple sclerosis: markers and mechanisms
|
Hohlfeld, Reinhard
|
|
2017
|
16 |
4 |
p. 259-261
3 p.
|
article
|
| 17 |
Richard Morris' Christmas lecture double-bill
|
Ranscombe, Peter
|
|
2017
|
16 |
4 |
p. 270-
1 p.
|
article
|
| 18 |
Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial
|
Zakrzewska, Joanna M
|
|
2017
|
16 |
4 |
p. 291-300
10 p.
|
article
|
| 19 |
Samuel Wiebe: new President of the International League Against Epilepsy
|
Burton, Adrian
|
|
2017
|
16 |
4 |
p. 267-
1 p.
|
article
|
| 20 |
Selective sodium channel blockers in trigeminal neuralgia
|
Jensen, Troels Staehelin
|
|
2017
|
16 |
4 |
p. 255-256
2 p.
|
article
|
| 21 |
Solving the conundrum of insoluble protein aggregates
|
George, Sonia
|
|
2017
|
16 |
4 |
p. 258-259
2 p.
|
article
|
| 22 |
Stakeholder collaboration for spinal muscular atrophy therapy development
|
Aartsma-Rus, Annemieke
|
|
2017
|
16 |
4 |
p. 264-
1 p.
|
article
|
| 23 |
The cause of stroke matters for secondary prevention
|
Diener, Hans-Christoph
|
|
2017
|
16 |
4 |
p. 256-257
2 p.
|
article
|
| 24 |
The prion model for progression and diversity of neurodegenerative diseases
|
Stopschinski, Barbara E
|
|
2017
|
16 |
4 |
p. 323-332
10 p.
|
article
|
| 25 |
The relevance of atrial fibrillation in stroke prevention
|
Testai, Fernando D
|
|
2017
|
16 |
4 |
p. 253-255
3 p.
|
article
|
| 26 |
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
|
Kalincik, Tomas
|
|
2017
|
16 |
4 |
p. 271-281
11 p.
|
article
|
| 27 |
What about a seizure-alert dog?
|
Burton, Adrian
|
|
2017
|
16 |
4 |
p. 265-266
2 p.
|
article
|
Journal description